One of the directions of R&D is the development of new methods and technologies for fundamental and applied research. The development program includes the following services:
• TECHNOLOGY DEVELOPMENT OF BIOPHARMACEUTICAL SUBSTANCES AND STERILE F&F PRODUCTION (IBH32);
• ADENO-ASSOCIATED AND LENTIVIRAL VECTORS FOR SCIENTIFIC RESEARCH AND GENE THERAPY (IBH34);
• RESEARCH AND CLINICAL APPLICATIONS ON AN OPEN-ARCHITECTURE OPTICAL BIOIMAGING MODULAR PLATFORM (IBH33);
• PRE-CLINICAL TRIALS (IBH36).